UnitedHealthcare
Duopa (carbidopa-levodopa)
Drugs for the Nervous System : Drugs for Parkinson
  • Prior Authorization: Parkinson's Disease:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Step Therapy: Parkinson's Disease:
    ST Single Generic

  • Parkinson's Disease:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Diagnosis Type(s): Advanced
    Clinically documented acute, intermittent treatment of hypomobility "off" episodes: Yes
    Concomitant Use of Max Tolerable Dose of levodopa + 1 selegiline,pramipexole,entacapone,rasagiline: No
    Use as adjunct therapy: No
    Requires concomitant anti-emetic agent: No

<< Return | Back to top